Hyperuricemia treatment: is creatinine clearance a safer allopurinol dosing meter than plasma creatinine levels?

被引：1
作者：
Robert Terkeltaub
机构：
[1] Chief of Rheumatology at the Veterans Affairs Medical Center and Professor of Medicine and Associate Division Director at the University of California,
来源：
Nature Clinical Practice Rheumatology | 2006年 / 2卷 / 2期
关键词：
D O I：
10.1038/ncprheum0099
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：68 / 69
页数：1
相关论文
共 6 条
[1]  
Bieber JD(2004)Gout: on the brink of novel therapeutic options for an ancient disease Arthritis Rheum 50 2400-2414
[2]  
Terkeltaub RA(2004)Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population J Rheumatol 31 1582-1587
[3]  
Wallace KL(2003)Clinical practice. Gout N Engl J Med 349 1647-1655
[4]  
Terkeltaub RA(1998)Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment Adv Exp Med Biol 431 13-18
[5]  
Yamanaka H(2001)Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 28 577-580
[6]  
Li-Yu J(undefined)undefined undefined undefined undefined-undefined
1